- Home
- SGA vs SRTS Comparison
SGA vs SRTS Comparison
Compare SGA & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGA | SRTS |
|---|---|---|
| Founded | 1986 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.6M | 48.9M |
| IPO Year | 1994 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SGA | SRTS |
|---|---|---|
| Price | $9.64 | $2.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 12.9K | ★ 17.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 9.05% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $124,829,000.00 | $27,482,000.00 |
| Revenue This Year | $6.74 | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.65 | N/A |
| 52 Week Low | $8.24 | $2.66 |
| 52 Week High | $13.50 | $5.49 |
Technical Indicators
Market Signals| Indicator | SGA | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 59.98 | 42.70 |
| Support Level | $8.26 | $2.87 |
| Resistance Level | $12.13 | $3.17 |
| Average True Range (ATR) | 0.44 | 0.12 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 82.25 | 18.52 |
Price Performance
Historical ComparisonAbout SGA Saga Communications Inc. (FL)
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.